I-Shu Chen
Impact in
- Hepatology top 5%
- Hepatocellular Carcinoma Treatment and Prognosis
- Liver physiology and pathology
- Pharmacology top 5%
- Drug-Induced Hepatotoxicity and Protection
- Healthcare and Venom Research
Papers in ⓘ
-
- Hepatocellular Carcinoma Treatment and Prognosis 6
- Co-authors
- Yi‐Chen Chen (3 shared papers)Shiuh‐Inn Liu (16 shared papers)Chih‐Hsien Chiu (2 shared papers)Yu‐Chia Chen (8 shared papers)Cheng‐Chung Tsai (8 shared papers)Chung‐Ren Jan (17 shared papers)Being‐Whey Wang (8 shared papers)Chung‐Hsi Chou (1 shared paper)
- Journals
- Journal of Personalized Medicine (3 papers)European Journal of Pharmacology (2 papers)Journal of the American College of Surgeons (2 papers)International Journal of Surgery (1 paper)Journal of the Science of Food and Agriculture (1 paper)
- Partner nations
- Taiwan
In The Last Decade
I-Shu Chen
43 papers receiving 840 citations
Peers
Comparison fields: 5 of 94
- Hepatology 214
- Pharmacology 104
- Molecular Medicine 46
- Pharmacology 105
- Surgery 251
Countries citing papers authored by I-Shu Chen
This map shows the geographic impact of I-Shu Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by I-Shu Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites I-Shu Chen more than expected).
Fields of papers citing papers by I-Shu Chen
This network shows the impact of papers produced by I-Shu Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by I-Shu Chen. The network helps show where I-Shu Chen may publish in the future.
Co-authors
The 25 scholars most cited alongside I-Shu Chen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 43 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2011 | 100 | |
| 2 | 2012 | 98 | |
| 3 | 2006 | 66 | |
| 4 | 2003 | 63 | |
| 5 | 2011 | 59 | |
| 6 | 2011 | 53 | |
| 7 | 2006 | 46 | |
| 8 | 2017 | 32 | |
| 9 | 2017 | 30 | |
| 10 | 2008 | 28 | |
| 11 | 2017 | 27 | |
| 12 | 2011 | 24 | |
| 13 | 2012 | 23 | |
| 14 | 1998 | 19 | |
| 15 | 2019 | 19 | |
| 16 | 2006 | 14 | |
| 17 | 2011 | 12 | |
| 18 | 2016 | 12 | |
| 19 | Effects of antrodia camphorata on viability, apoptosis, and [Ca2+]i in PC3 human prostate cancer cells. | 2008 | 12 |
| 20 | 2016 | 11 |
About I-Shu Chen
I-Shu Chen is a scholar working on Hepatology, Toxicology, Sensory Systems, Cellular and Molecular Neuroscience and Surgery, having authored 43 papers that have together received 854 indexed citations. Recurring topics across this work include Ion channel regulation and function (9 papers), Neuroscience and Neuropharmacology Research (7 papers), Hepatocellular Carcinoma Treatment and Prognosis (6 papers), Pharmacological Receptor Mechanisms and Effects (4 papers), Thyroid and Parathyroid Surgery (4 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (4 papers), Gastric Cancer Management and Outcomes (3 papers) and Liver Disease Diagnosis and Treatment (3 papers). The work is most often cited by research in Hepatology (214 citations), Pharmacology (104 citations), Molecular Medicine (46 citations), Pharmacology (105 citations) and Surgery (251 citations). I-Shu Chen has collaborated with scholars based in Taiwan. Frequent co-authors include Yi‐Chen Chen, Shiuh‐Inn Liu, Chih‐Hsien Chiu, Yu‐Chia Chen, Cheng‐Chung Tsai, Chung‐Ren Jan, Being‐Whey Wang, Chung‐Hsi Chou, Lee‐Yan Sheen and Hong‐Tai Chang. Their work appears in journals such as Journal of Personalized Medicine, European Journal of Pharmacology, Journal of the American College of Surgeons, International Journal of Surgery and Journal of the Science of Food and Agriculture.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.